Moonshots with Peter Diamandis

Investors should consider Alphabet (GOOGL) as it leverages its massive 13-product ecosystem to deploy Gemini AI to billions, effectively defending its search moat against smaller disruptors. Watch for the newly public Cerebras Systems, which positions itself as the primary NVIDIA challenger with hardware optimized for the high-growth AI inference market. Monitor Meta and Google as they compete in the emerging Smart Eyewear sector, with a major shift toward audio-first ambient AI expected by 2025. High-conviction opportunities are also emerging in AI Infrastructure, specifically companies solving power and cooling bottlenecks for data centers as CapEx spending hits record highs. For long-term growth, focus on the "Verification Age" by investing in cryptographic and watermarking technologies like SynthID that secure AI-generated content.

Investors should prioritize exposure to the "Singularity Loop" by holding a basket of core chip stocks including Nvidia (NVDA), AMD, and TSMC (TSM), which have significantly outperformed the broader market. Anthropic’s massive revenue surge makes it a primary demand driver for Amazon (AMZN) and Nvidia hardware, while its $1.8B deal with Akamai (AKAM) highlights a high-growth infrastructure play. OpenAI’s upcoming "Super App" and 16-gigawatt power expansion pose a direct threat to Apple (AAPL) and Google (GOOGL), signaling a shift toward AI-driven operating systems. Energy and cooling infrastructure remain the ultimate bottlenecks; look for unpriced opportunities in liquid cooling components and energy providers supporting massive data center builds. As AI agents begin to automate the $1T legal and professional services sectors, traditional SaaS models are at risk, favoring companies that pivot to "outcome-based" pricing rather than seat licenses.

Investors should prioritize Alphabet (GOOGL) as it transitions into an AI infrastructure powerhouse, leveraging its industry-leading Cloud growth and custom TPU chips to create a dominant, vertically integrated moat. In the semiconductor space, maintain exposure to NVIDIA (NVDA) while considering Intel (INTC) as a strategic play on domestic manufacturing and national security tailwinds. Look beyond software to the "physical layer" of AI by investing in cooling systems, energy providers, and memory manufacturers like Samsung or SanDisk to capture the surge in data center demand. For private market exposure, focus on "orchestration layer" companies like Blitzy that provide autonomous enterprise solutions rather than simple model wrappers. Be cautious of OpenAI's delayed IPO (projected for 2027) and instead watch for Microsoft (MSFT) to develop in-house models as their exclusive partnership cools.

Investors should prioritize companies controlling the compute supply chain, such as data centers and specialized hardware providers, to capitalize on the massive compute shortfall expected by 2028. Eli Lilly (LLY) remains a high-conviction play as its new "triple agonist" peptide, Retatrutide, shows superior clinical results for weight loss and liver health compared to current market leaders. The investment value is shifting from pure software toward Physical AI, making humanoid robotics leaders like Tesla (TSLA), Figure AI, and 1X Technologies essential long-term holdings as they scale toward millions of units by 2030. Look for "pick and shovel" opportunities in the robotics sector, specifically in specialized insurance and maintenance services for autonomous fleets. Monitor Colossal Biosciences and related synthetic biology firms for breakthroughs in CRISPR technology, which will likely yield high-value applications in human healthcare and agriculture by 2028.

Investors should prioritize Google (GOOGL) for its unique vertical integration, as it designs proprietary TPU chips while simultaneously securing nearly one million NVIDIA GPUs to build the world’s largest AI cloud infrastructure. TSMC (TSM) remains the essential "bottleneck" play, as every major AI developer is entirely dependent on their fabrication capacity to meet surging hardware demand. For exposure to the private AI boom, look for secondary market opportunities in Anthropic, which is seeing massive revenue velocity and multi-billion dollar backing from Amazon and Google. The energy sector is a critical secondary play, specifically Nuclear and Small Modular Reactors (SMRs), which are required to power the next generation of "Gigawatt" data centers. In healthcare, Moderna (MRNA) is a high-conviction leader as AI-driven drug discovery transforms biology into a scalable engineering problem, evidenced by recent breakthroughs in mRNA cancer trials.

Investors should focus on GLP-1 leaders like Novo Nordisk (NVO) and Eli Lilly (LLY) as these drugs expand into massive heart and brain health markets beyond simple weight loss. Monitor clinical trial results from Life Biosciences regarding their ER100 gene therapy, which aims to reverse vision loss and cellular aging. For cardiovascular health, prioritize companies developing PCSK9 inhibitors as superior alternatives to statins for reversing plaque buildup. Look for AI-driven biotech startups that utilize transcriptomic data and agentic systems like Cadence to accelerate drug discovery timelines. When evaluating early-stage longevity investments, ensure the company has a high-conviction team and enough capital runway to survive the transition from academic research to clinical trials.

Investors should closely monitor Life Biosciences as it initiates human clinical trials for OSK gene therapy, targeting glaucoma and blindness with data expected by 2026. While gene therapies are currently high-cost, the most scalable opportunity lies in AI-driven small molecules (pills) that aim to mimic age-reversal effects for a mass-market audience. Watch for the "cocktail" of longevity molecules entering human trials via the Healthspan XPRIZE within the next few months as a major catalyst for the sector. In the consumer health space, there is growing demand for NMN, Resveratrol, and Nattokinase, the latter of which is being studied for its potential to reverse arterial plaque. For diversified exposure, focus on the Bio-IT sector, where Artificial Intelligence is significantly accelerating the timeline and reducing the cost of drug discovery for age-related diseases.

Investors should reduce exposure to traditional SaaS "wrappers" like Adobe (ADBE) and Figma, as frontier labs like Anthropic are now integrating these design and coding capabilities directly into their AI models. Keep a close watch on OpenAI for a potential IPO in late 2024 or 2025, as the company aggressively pivots from research toward enterprise profitability and "AI-native" professional workflows. Monitor the SpaceX and XAI ecosystem for a massive $60 billion acquisition of Cursor, signaling that AI-driven code generation is the primary high-value frontier for achieving AGI. Maintain long-term positions in data center infrastructure and U.S. Robotics, as private capital expenditure in these sectors is currently outpacing historic government programs like the Apollo mission. To hedge against geopolitical "system shocks," diversify away from semiconductor reliance on the Middle East, as a conflict in the Strait of Hormuz could cripple global chip manufacturing by cutting off critical supplies of helium and neon.

Investors should monitor Amazon (AMZN) and Apple (AAPL) as they leverage the Globalstar acquisition to challenge SpaceX in the "Direct-to-Cell" satellite market. Focus on companies holding S-band spectrum licenses, as these assets are becoming high-value acquisition targets for global mobile connectivity. In the AI sector, prioritize Anthropic’s Claude Opus 4.7 for enterprise workflow automation, specifically for its ability to analyze complex corporate documents and PDFs via expanded vision capabilities. Due to increasing data center bans in states like Maine, look for geographic arbitrage opportunities in pro-AI regions like New Hampshire and Texas that offer a "Right to Compute." Finally, consider exposure to modular nuclear or off-grid energy solutions, as data centers are increasingly forced to bypass the traditional power grid to meet massive energy demands.

Investors should prioritize NVIDIA (NVDA) as the essential "picks and shovels" play, as massive hardware spending by AI labs continues to drive corporate revenue gains. In the private markets, Anthropic is currently seeing triple the investor demand of OpenAI, making it the high-conviction "pure-play" competitor to watch for enterprise AI growth. Monitor the OpenAI fraud trial beginning April 27th, as any court-ordered restructuring or leadership changes involving Sam Altman could significantly devalue private holdings. For exposure to AI-driven drug discovery, look toward Eli Lilly (LLY) and its partnerships with AI-first firms like Insilico Medicine to capitalize on faster clinical trial success rates. Finally, Bitcoin (BTC) remains a high-conviction "hardened" asset for long-term holders, with major institutional buyers like MicroStrategy continuing multi-billion dollar accumulations despite future quantum computing concerns.

Prepare for a generational investment opportunity in SpaceX, which is targeting a $2 trillion IPO valuation driven by the massive profitability of Starlink and a 100% year-over-year revenue growth rate. Monitor secondary markets for Anthropic, as it has overtaken OpenAI in annual revenue and is positioned as the dominant enterprise AI leader ahead of a potential 2026 IPO. Consider Intel (INTC) as a strategic turnaround play due to its $25 billion "TerraFab" partnership with XAI, which aims to move leading-edge chip manufacturing to the U.S. and reduce dependency on TSMC. Investors should pivot away from traditional luxury commodities like De Beers diamonds, as lab-grown technology has triggered an 80% price collapse and destroyed the scarcity model. Look for emerging opportunities in Orbital Data Centers and Solar Robotics, which solve the terrestrial power and equipment shortages currently delaying 50% of land-based AI projects.

Investors should monitor Colossal Biosciences as a foundational platform play in synthetic biology, utilizing AI to transform genetic engineering into a scalable industrial software model. While the company is currently private, its spin-out Breaking offers a high-conviction opportunity in the "circular economy" by using engineered enzymes to fully eliminate plastic waste. Significant revenue potential exists in Genetic Biocontrol, a $5.4 trillion market where biological tools are replacing toxic chemicals to manage invasive species for government contracts. The company’s acquisition of Viogen provides immediate cash flow through high-efficiency animal cloning, while its breakthroughs in IVF tech and artificial wombs represent massive licensing opportunities in human healthcare. Treat this sector as the next trillion-dollar frontier, where "de-extinction" serves as the R&D catalyst for immediate applications in agriculture, medicine, and environmental remediation.

Uber (UBER) is transitioning into a high-conviction cash flow play with a projected $10 billion in annual cash flow, making it the dominant software layer for the upcoming autonomous vehicle (AV) era. Investors should view UBER as an asset-light way to play the AV market, as the company scales partnerships with hardware providers like BYD, Pony.ai, and WeRide rather than building its own vehicles. For exposure to the future of urban air mobility, Joby Aviation (JOBY) remains a key strategic partner as Uber integrates "flying taxi" infrastructure and data-driven vertiports into its app. The shift from human drivers to autonomous fleets will disrupt the insurance sector, moving the industry toward "product liability" models and significantly lowering long-term operating costs for ride-share platforms. While regulatory hurdles remain, the 10-year outlook suggests a total transformation of transportation, favoring companies that control the consumer interface and global logistics network.

Investors should consider Uber (UBER) as a long-term play on the "operating system" for autonomous transport, with the company aiming to dominate the robotaxi marketplace by 2029. To gain exposure to the underlying autonomous software and hardware, look toward key partners Waymo (GOOGL), NVIDIA (NVDA), and Wayve, as the industry shifts from vehicle ownership to software-driven networks. For those interested in the "flying car" and drone delivery sector, Joby Aviation (JOBY) remains the primary partner for vertical takeoff, with commercial launches expected in the Middle East by late 2024 and the U.S. by 2025/2026. Lucid (LCID) is a specific hardware pick to watch, as its vehicles are already built with the redundant systems necessary for immediate autonomous integration. Monitor the Middle East and UK markets as leading regulatory indicators, as these regions will serve as the initial testing grounds for high-conviction technologies before they scale globally.

Investors should prioritize the "innermost loop" of the AI supply chain by holding Tesla (TSLA) and monitoring SpaceX for a potential IPO, as these entities aim to control 50x the world's current AI compute through the TerraFab project. In the transportation sector, Uber (UBER) is a high-conviction play as it transitions to "Transportation as a Service" through partnerships with Waymo and Rivian. For exposure to the future of autonomous flight, Joby Aviation (JOBY) and Archer Aviation (ACHR) are the primary tickers to watch as they achieve critical FAA compliance milestones. Shift capital away from traditional software (SaaS) and toward physical infrastructure, specifically companies focused on energy generation and data center power, which act as the ultimate bottleneck for AI growth. Finally, consider real estate in "second-tier" scenic areas that will see a value surge as autonomous vehicles and eVTOLs make remote locations more accessible for daily commuting.

Investors should prioritize NVIDIA (NVDA) for its dominant Rubin architecture and Google (GOOGL) for its cost-efficient TPU inference engines as the industry shifts toward autonomous "reasoning agents." To capitalize on the massive 92-gigawatt U.S. power shortage, focus on nuclear energy, grid modernization, and liquid-cooling infrastructure providers. The "Year of Agents" favors a barbell strategy: hold "hyperscalers" for compute and small, AI-driven startups that use Claude (Anthropic) to automate 80% of traditional coding workflows. In the robotics sector, look for vertically integrated leaders like Tesla (TSLA) and Figure AI to compete with Chinese hardware dominance. For high-risk, long-term growth, monitor heavy-lift providers like SpaceX as the "business case" for rockets evolves toward launching space-based data centers.

Investors should maintain core exposure to NVIDIA (NVDA) as it tracks toward a $1 trillion revenue target by 2027, while monitoring ASML shipments as a leading indicator for chip supply capacity. To capitalize on the massive AI power demand, pivot toward the nuclear energy sector, specifically companies developing Small Modular Reactors (SMRs) and firms like TerraPower or Meta (META) that are securing long-term nuclear contracts. Amazon (AMZN) offers a strategic entry into both enterprise AI through its partnership with Anthropic and the "Physical AI" revolution as it scales its internal robotics fleet. Keep a close watch for a potential Anthropic IPO, as the company is currently dominating the high-value enterprise market with a 73% share of new corporate customers. For long-term growth, treat Tesla (TSLA) as a robotics and compute play rather than an automaker, focusing on the scaling of the Optimus bot and their move toward independent chip manufacturing.

Investors should monitor Tesla (TSLA) for a major valuation milestone in mid-2025 as the company transitions from prototypes to high-volume production of the Optimus humanoid robot. In the AI sector, xAI is aggressively targeting the coding niche with its Grok model, aiming to outperform competitors by mid-2024. While SpaceX remains private, it is evolving into a primary infrastructure play for lunar bases and off-world energy, creating long-term synergies with Musk’s AI ventures. The broader Robotics and AI sectors are positioned for massive growth, with Musk predicting a 10x expansion of the global economy over the next decade driven by productivity gains. For those interested in frontier technology, the Bio-engineering and Synthetic Biology themes are emerging through companies like Colossal, which is currently working on species de-extinction.

Investors should prioritize Energy and Infrastructure stocks, specifically those focused on Nuclear (SMRs) and Solar, as firms like xAI require gigawatt-scale power that exceeds current grid capacities. Meta (META) is a high-conviction play for the next era of social media following its acquisition of Moltbook, signaling a shift toward monetizing AI agent ecosystems rather than just human users. Watch for a massive catalyst in Apple (AAPL) if they "unlock" their M5 silicon for local AI processing, which would instantly create the world’s largest edge-computing network. The legal and professional services sectors face significant disruption risks; consider hedging or reducing exposure to traditional firms as Anthropic’s Claude and OpenAI’s GPT-5 begin automating high-level reasoning and research. For long-term "moonshot" growth, monitor the Whole Brain Emulation (WBE) space and Humanoid Robotics (e.g., Tesla's Optimus), with significant commercial deployments expected by 2028.

Investors should prioritize companies like Block (SQ) that are aggressively optimizing for efficiency by replacing entry-level white-collar roles with AI-driven "column" structures. To hedge against digital displacement, shift capital toward skilled trades and infrastructure services—specifically electrical grid upgrades and data center construction—which remain insulated from robotics for at least a decade. Be extremely cautious with traditional office REITs and residential real estate in white-collar commuter hubs, as shrinking corporate headcounts may trigger a wave of forced home sales and commercial devaluations. Monitor the "loneliness economy" for growth opportunities in emotional AI and personalized digital companionship, sectors poised to capture a generation increasingly seeking frictionless, AI-driven social interaction. Finally, watch for a 2026–2028 volatility window where social unrest could peak; consider diversifying into Universal Basic Services models, such as Mark Cuban Cost Plus Drugs, which benefit from the hyper-deflation of essential goods.